Viking Therapeutics (VKTX) released new ... new weight-loss drug alternatives to current market leaders like Wegovy, Zepbound ...

The findings were recently published in the New England Journal of Medicine ... While it remains unclear precisely how these ...

“I’m playing doctor,” Bookless said, describing her foray into the world of do-it-yourself GLP-1 medication, injections ...

Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 ...

Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to traditional pharmacological interventions.

Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...

Online pharmacies are the only way to get weight loss injections for most people, but doctors are concerned some firms do not ...

The Denmark-based drug maker Zealand Pharma said Tuesday that its experimental weight-loss drug could help patients lose ...

Dulaglutide is another GLP-1 injection available under the brand name Trulicity®. This medication is FDA-approved for type 2 diabetes but is sometimes prescribed off-label for weight loss.

An injection pen of Zepbound, Eli Lilly’s weight-loss drug, is displayed in New York City, December 11 ... Novo and Lilly ...

Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...